{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T10:34:44Z","timestamp":1723631684295},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,4,26]],"date-time":"2014-04-26T00:00:00Z","timestamp":1398470400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Health"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1742-4755-11-33","type":"journal-article","created":{"date-parts":[[2014,4,26]],"date-time":"2014-04-26T21:01:27Z","timestamp":1398546087000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Metabolic effects of the contraceptive skin patch and subdermal contraceptive implant in Mexican women: A prospective study"],"prefix":"10.1186","volume":"11","author":[{"given":"Jesus","family":"Hernandez-Juarez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ethel A","family":"Garcia-Latorre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Moreno-Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Fernando","family":"Moran-Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel Angel","family":"Rodriguez-Escobedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerardo","family":"Cogque-Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rub\u00e9n","family":"Juli\u00e1n-Nacer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xochitl","family":"Hernandez-Giron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosalia","family":"Palafox-Gomez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irma","family":"Isordia-Salas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abraham","family":"Majluf-Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,26]]},"reference":[{"key":"360_CR1","first-page":"1","volume":"877","author":"World Health Organization","year":"1998","unstructured":"World Health Organization: Cardiovascular Disease and Steroid Hormone Contraception. Report of a WHO Scientific group. World Health Organ Tech Rep Ser. 1998, 877: 1-89.","journal-title":"World Health Organ Tech Rep Ser"},{"key":"360_CR2","unstructured":"Instituto Nacional de Estad\u00edstica, Geograf\u00eda e Inform\u00e1tica. Mexico: Estad\u00edsticas generales.http:\/\/dgcnesyp.inegi.gob.mx,"},{"key":"360_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1067\/mob.2002.118844","volume":"186","author":"R Dittrich","year":"2002","unstructured":"Dittrich R, Parker L, Rosen JB, Shangold G, Creasy GW, Fisher AC, Ortho Evra\/Evra 001 Study Group: Transdermal contraception: evaluation of three transdermal norelgestromin\/ethinyl estradiol doses in a randomized, multicentre, dose\u2013response study. Am J Obstet Gynecol. 2002, 186: 15-20. 10.1067\/mob.2002.118844.","journal-title":"Am J Obstet Gynecol"},{"key":"360_CR4","unstructured":"Janssen-Cilag International NV: Evra transdermal patch. Summary of product characteristics.http:\/\/www.janssen-cilag.co.uk\/product\/pdf\/spc\/00121.pdf,"},{"issue":"Suppl 1","key":"360_CR5","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/S0015-0282(01)03261-7","volume":"77","author":"LS Abrams","year":"2002","unstructured":"Abrams LS, Skee D, Natarajan J, Wong FA: Pharmacokinetic overview of Ortho EvraTM\/EvraTM. Fertil Steril. 2002, 77 (Suppl 1): S3-S12.","journal-title":"Fertil Steril"},{"key":"360_CR6","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1177\/00912700122012788","volume":"41","author":"LS Abrams","year":"2001","unstructured":"Abrams LS, Skee DM, Wong FA, Anderson NJ, Leese PT: Pharmacokinetics of norelgestromin and ethinyl estradiol from two consecutive contraceptive patches. J Clin Pharmacol. 2001, 41: 1232-1237. 10.1177\/00912700122012788.","journal-title":"J Clin Pharmacol"},{"key":"360_CR7","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1046\/j.0306-5251.2001.01532.x","volume":"53","author":"LS Abrams","year":"2001","unstructured":"Abrams LS, Skee D, Natarajan J, Wong FA, Anderson GD: Pharmacokinetics of a contraceptive patch (EvraTM\/Ortho EvraTM) containing norelgestromin and ethinyloestradiol at four application sites. J Clin Pharmacol. 2001, 53: 141-146.","journal-title":"J Clin Pharmacol"},{"key":"360_CR8","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1001\/jama.285.18.2347","volume":"285","author":"MC Audet","year":"2001","unstructured":"Audet MC, Moreau M, Koltun WD, Waldbaum AS, Shangold G, Fisher AC, Creasy GW, ORTHO, EVRA\/EVRA 004 Study Group: Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs. an oral contraceptive. JAMA. 2001, 285: 2347-2355. 10.1001\/jama.285.18.2347.","journal-title":"JAMA"},{"key":"360_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0010-7824(01)00294-3","volume":"65","author":"HB Croxatto","year":"2002","unstructured":"Croxatto HB: Mechanisms that explain the contraceptive action of progestin implants for women. Contraception. 2002, 65: 21-27. 10.1016\/S0010-7824(01)00294-3.","journal-title":"Contraception"},{"key":"360_CR10","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/0010-7824(91)90030-J","volume":"44","author":"S Diaz","year":"1991","unstructured":"Diaz S, Pavez M, Moo-Young AJ, Bardin CW, Croxatto HB: Clinical trial with 3-keto-desogestrel subdermal implants. Contraception. 1991, 44: 393-408. 10.1016\/0010-7824(91)90030-J.","journal-title":"Contraception"},{"key":"360_CR11","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/0010-7824(93)90042-6","volume":"47","author":"GC Davies","year":"1993","unstructured":"Davies GC, Feng LX, Newton JR, Van Beek A, Coelingh-Bennink HJ: Release characteristics, ovarian activity and menstrual bleeding pattern with a single contraceptive implant releasing 3-ketodesogestrel. Contraception. 1993, 47: 251-261. 10.1016\/0010-7824(93)90042-6.","journal-title":"Contraception"},{"key":"360_CR12","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/S0015-0282(98)00015-6","volume":"69","author":"L Makarainen","year":"1998","unstructured":"Makarainen L, van Beek A, Tuomivaara L, Asplund B, Coelingh Bennink H: Ovarian function during the use of a single contraceptive implant: Implanon compared with Norplant. Fertil Steril. 1998, 69: 714-721. 10.1016\/S0015-0282(98)00015-6.","journal-title":"Fertil Steril"},{"issue":"Suppl 2","key":"360_CR13","doi-asserted-by":"publisher","first-page":"91S","DOI":"10.1016\/S0010-7824(98)00118-8","volume":"58","author":"HB Croxatto","year":"1998","unstructured":"Croxatto HB, Makarainen L: The pharmacodynamics and efficacy of Implanon. An overview of the data. Contraception. 1998, 58 (Suppl 2): 91S-97S.","journal-title":"Contraception"},{"key":"360_CR14","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1016\/j.fertnstert.2008.02.140","volume":"91","author":"P Darney","year":"2009","unstructured":"Darney P, Patel A, Rosen K, Shapiro LS, Kaunitz AM: Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials. Fertil Steril. 2009, 91: 1646-1653. 10.1016\/j.fertnstert.2008.02.140.","journal-title":"Fertil Steril"},{"key":"360_CR15","first-page":"395","volume":"68","author":"R Lisker","year":"1996","unstructured":"Lisker R, Ram\u00edrez E, Babinsky V: Genetic structure of autochtonous populations of Meso-America: Mexico. Human Biol. 1996, 68: 395-404.","journal-title":"Human Biol"},{"key":"360_CR16","first-page":"884","volume":"76","author":"S Radowicki","year":"2005","unstructured":"Radowicki S, Sk\u00f3rzewska K, Szlendak K: Safety evaluation of a transdermal contraceptive system with an oral contraceptive. Ginekol Pol. 2005, 76: 884-889.","journal-title":"Ginekol Pol"},{"key":"360_CR17","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3109\/09513590903511455","volume":"26","author":"O Kiriwat","year":"2010","unstructured":"Kiriwat O, Petyim S: The effects of transdermal contraception on lipid profiles, carbohydrate metabolism and coagulogram in Thai women. Gynecol Endocrinol. 2010, 26: 361-365. 10.3109\/09513590903511455.","journal-title":"Gynecol Endocrinol"},{"key":"360_CR18","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/AOG.0b013e3181626d1b","volume":"11","author":"JV Johnson","year":"2008","unstructured":"Johnson JV, Lowell J, Badger GJ, Rosing J, Tchaikovski S, Cushman M: Effects of oral and transdermal hormonal contraception on vascular risk markers: a randomized controlled trial. Obstet Gynecol. 2008, 11: 278-284.","journal-title":"Obstet Gynecol"},{"key":"360_CR19","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.thromres.2008.04.022","volume":"123","author":"K Fleischer","year":"2009","unstructured":"Fleischer K, van Vliet HA, Rosendaal FR, Rosing J, Tchaikovski S, Helmerhorst FM: Effects of the contraceptive patch, the vaginal ring and an oral contraceptive on APC resistance and SHBG: a cross-over study. Thromb Res. 2009, 123: 429-435. 10.1016\/j.thromres.2008.04.022.","journal-title":"Thromb Res"},{"issue":"Suppl 1","key":"360_CR20","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1016\/S0015-0282(01)03264-2","volume":"77","author":"BM Sibai","year":"2002","unstructured":"Sibai BM, Odlind V, Meador ML, Shangold GA, Fisher AC, Creasy GW: A comparative and pooled analysis of the safety and tolerability of the contraceptive patch (Ortho Evra\/Evra). Fertil Steril. 2002, 77 (Suppl 1): S19-S26.","journal-title":"Fertil Steril"},{"key":"360_CR21","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/S0029-7844(01)01534-4","volume":"98","author":"GH Smallwood","year":"2001","unstructured":"Smallwood GH, Meador ML, Lenihan JP, Shangold GA, Fisher AC, Creasy W: ORTHO EVRA\/EVRA 002 Study Group: Efficacy and safety of a transdermal contraceptive system. Obstet Gynecol. 2001, 98: 799-805. 10.1016\/S0029-7844(01)01534-4.","journal-title":"Obstet Gynecol"},{"key":"360_CR22","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jpag.2004.11.016","volume":"18","author":"Z Harel","year":"2005","unstructured":"Harel Z, Riggs S, Vaz R, Flanagan P, Dunn K, Harel D: Adolescents' experience with the combined estrogen and progestin transdermal contraceptive method Ortho Evra. J Pediatr Adolesc Gynecol. 2005, 18: 85-90. 10.1016\/j.jpag.2004.11.016.","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"360_CR23","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1160\/TH05-03-0682","volume":"94","author":"CS Vieira","year":"2005","unstructured":"Vieira CS, Ferriani RA, Garcia AA, Gomes MK, Azevedo GD, de S\u00e1 MF S: Transitory reduction of platelet aggregation with the use of etonogestrel implant in healthy women. Thromb Haemost. 2005, 94: 682-683.","journal-title":"Thromb Haemost"},{"key":"360_CR24","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0010-7824(98)00070-5","volume":"58","author":"N Egberg","year":"1998","unstructured":"Egberg N, van Beek A, Gunnervik C, Hulkko S, Hirvonen E, Larsson-Cohn U, Bennink HC: Effects on the hemostatic system and liver function in relation to Implanon and Norplant. A prospective randomized clinical trial. Contraception. 1998, 58: 93-98. 10.1016\/S0010-7824(98)00070-5.","journal-title":"Contraception"},{"key":"360_CR25","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0010-7824(03)00145-8","volume":"68","author":"A Biswas","year":"2003","unstructured":"Biswas A, Viegas OA, Roy AC: Effect of Implanon and Norplant subdermal contraceptive implants on serum lipids\u2014a randomized comparative study. Contraception. 2003, 68: 189-193. 10.1016\/S0010-7824(03)00145-8.","journal-title":"Contraception"},{"key":"360_CR26","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-2265.2007.03046.x","volume":"68","author":"GS Merki-Feld","year":"2008","unstructured":"Merki-Feld GS, Imthurn B, Seifert B: Effects of the progestagen-only contraceptive implant Implanon on cardiovascular risk factors. Clin Endocrinol (Oxf). 2008, 68: 355-360.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"360_CR27","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.contraception.2004.05.011","volume":"70","author":"A Biswas","year":"2004","unstructured":"Biswas A, Biswas S, Viegas OA: Effect of etonogestrel subdermal contraceptive implant (Implanon) on liver function tests\u2014a randomized comparative study with Norplant implants. Contraception. 2004, 70: 379-382. 10.1016\/j.contraception.2004.05.011.","journal-title":"Contraception"},{"key":"360_CR28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0010-7824(01)00289-X","volume":"65","author":"V Brache","year":"2002","unstructured":"Brache V, Faundes A, Alvarez F, Cochon L: Non-menstrual adverse events during use of implantable contraceptives for women: data from clinical trials. Contraception. 2002, 65: 63-74. 10.1016\/S0010-7824(01)00289-X.","journal-title":"Contraception"},{"key":"360_CR29","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0021-9258(17)40889-1","volume":"253","author":"E Rinderknecht","year":"1978","unstructured":"Rinderknecht E, Humbel RE: The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. J Biol Chem. 1978, 253: 2769-2776.","journal-title":"J Biol Chem"},{"key":"360_CR30","first-page":"1518","volume":"85","author":"DR Clemmons","year":"2000","unstructured":"Clemmons DR, Moses AC, McKay MJ, Sommer A, Rosen DM, Ruckle J: The combination of insulin-like growth factor I and insulin-like growth factor binding protein-3 reduces insulin requirements in insulin-dependent type 1 diabetes: evidence for in vivo biological activity. J Clin Endocrinol Metab. 2000, 85: 1518-1524.","journal-title":"J Clin Endocrinol Metab"},{"key":"360_CR31","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1046\/j.1365-2362.1999.00522.x","volume":"29","author":"G Paolisso","year":"1999","unstructured":"Paolisso G, Tagliamonte MR, Rizzo MR, Giugliano D: Advancing age and insulin resistance: new facts about an ancient history. Eur J Clin Invest. 1999, 29: 758-769. 10.1046\/j.1365-2362.1999.00522.x.","journal-title":"Eur J Clin Invest"},{"key":"360_CR32","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.contraception.2010.02.010","volume":"82","author":"CA Guazzelli","year":"2010","unstructured":"Guazzelli CA, de Queiroz FT, Barbieri M, Torloni MR, de Araujo FF: Etonogestrel implant in postpartum adolescents: bleeding pattern, efficacy and discontinuation rate. Contraception. 2010, 82: 256-259. 10.1016\/j.contraception.2010.02.010.","journal-title":"Contraception"},{"key":"360_CR33","first-page":"262","volume":"58","author":"World Health Organization","year":"1998","unstructured":"World Health Organization: Effects of contraceptives on hemoglobin and ferritin. Task Force for Epidemiological Research on Reproductive Health, United Nations Development Programme\/United Nations Population Fund\/World Health Organization\/World Bank Special Programme of Research, Development and Research Training in Human Reproduction. Contraception. 1998, 58: 262-273.","journal-title":"Contraception"},{"key":"360_CR34","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.contraception.2011.02.006","volume":"84","author":"CA Guazzelli","year":"2011","unstructured":"Guazzelli CA, de Queiroz FT, Barbieri M, Barreiros FA, Torloni MR, Araujo FF: Metabolic effects of contraceptive implants in adolescents. Contraception. 2011, 84: 409-412. 10.1016\/j.contraception.2011.02.006.","journal-title":"Contraception"},{"key":"360_CR35","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1080\/13625180802075315","volume":"13","author":"MM Inal","year":"2008","unstructured":"Inal MM, Yildirim Y, Ertopcu K, Avci ME, Ozelmas I, Tinar S: Effect of the subdermal contraceptive Etonogestrel implant (Implanon) on biochemical and hormonal parameters (three years follow-up). Eur J Contracept Reprod Health Care. 2008, 13: 238-242. 10.1080\/13625180802075315.","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"360_CR36","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1006\/bbrc.1999.0255","volume":"257","author":"Y Arita","year":"1999","unstructured":"Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999, 257: 79-83. 10.1006\/bbrc.1999.0255.","journal-title":"Biochem Biophys Res Commun"},{"key":"360_CR37","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.pcad.2009.06.004","volume":"52","author":"SH Han","year":"2009","unstructured":"Han SH, Sakuma I, Shin EK, Koh KK: Antiatherosclerotic and anti-insulin resistance effects of adiponectin: basic and clinical studies. Prog Cardiovasc Dis. 2009, 52: 126-140. 10.1016\/j.pcad.2009.06.004.","journal-title":"Prog Cardiovasc Dis"},{"key":"360_CR38","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/sj.ijo.0803793","volume":"32","author":"J Hung","year":"2008","unstructured":"Hung J, McQuillan BM, Thompson PL, Beilby JP: Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity. Int J Obes. 2008, 32: 772-779. 10.1038\/sj.ijo.0803793.","journal-title":"Int J Obes"},{"key":"360_CR39","doi-asserted-by":"publisher","first-page":"93","DOI":"10.7326\/0003-4819-152-2-201001190-00008","volume":"152","author":"T Kelesidis","year":"2010","unstructured":"Kelesidis T, Kelesidis I, Chou S, Mantzoros CS: Narrative review: The role of leptin in human physiology: emerging clinical applications. Ann Intern Med. 2010, 152: 93-100. 10.7326\/0003-4819-152-2-201001190-00008.","journal-title":"Ann Intern Med"},{"key":"360_CR40","doi-asserted-by":"publisher","first-page":"611","DOI":"10.2337\/db09-1343","volume":"59","author":"Q Sun","year":"2010","unstructured":"Sun Q, van Dam RM, Meigs JB, Franco OH, Mantzoros CS, Hu FB: Leptin and soluble leptin receptor levels in plasma and risk of type 2 diabetes in U.S. women: a prospective study. Diabetes. 2010, 59: 611-618. 10.2337\/db09-1343.","journal-title":"Diabetes"},{"key":"360_CR41","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1161\/01.CIR.0000053730.47739.3C","volume":"107","author":"PM Ridker","year":"2003","unstructured":"Ridker PM: Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003, 107: 363-369. 10.1161\/01.CIR.0000053730.47739.3C.","journal-title":"Circulation"},{"key":"360_CR42","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/nature01323","volume":"420","author":"P Libby","year":"2002","unstructured":"Libby P: Inflammation in atherosclerosis. Nature. 2002, 420: 868-874. 10.1038\/nature01323.","journal-title":"Nature"}],"container-title":["Reproductive Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-4755-11-33.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1742-4755-11-33\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-4755-11-33","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-4755-11-33.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T11:21:26Z","timestamp":1630581686000},"score":1,"resource":{"primary":{"URL":"https:\/\/reproductive-health-journal.biomedcentral.com\/articles\/10.1186\/1742-4755-11-33"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,26]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["360"],"URL":"https:\/\/doi.org\/10.1186\/1742-4755-11-33","relation":{},"ISSN":["1742-4755"],"issn-type":[{"value":"1742-4755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,26]]},"assertion":[{"value":"19 October 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"33"}}